Open access
958
Views
0
CrossRef citations to date
0
Altmetric
Drug Evaluation
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase
Xiao-Jian ZhouDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USACorrespondence[email protected]
https://orcid.org/0009-0009-7662-1616View further author information
Steven S GoodDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information
, Keith PietropaoloDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information
, Qi HuangDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information
, Adel MoussaDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information
, Janet MJ HammondDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information
& Jean-Pierre SommadossiDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information
show all
Pages 9-17
|
Received 20 Sep 2023, Accepted 10 Jan 2024, Published online: 24 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.